Blood flow and thrombus formation determine the development of stent neointima

Journal of Long-Term Effects of Medical Implants

Volumn 10, Issue 1-2, 2000, Pages 69-77

  Richter, Goetz M ^a   Palmaz, Julio C ^b   Noeldge, Gerd ^a   Tio, Fermin ^c  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Antithrombotic drugs; Stent restenosis; Stent thrombosis

Indexed keywords

ANGIOGRAPHY; BLOOD VESSELS; HEMODYNAMICS; POLYSACCHARIDES;

ANTITHROMBOTIC DRUG; HEPARINIZATION; STENT RESTENOSIS; STENT THROMBOSIS;

IMPLANTS (SURGICAL);

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD FLOW; DOG; HISTOPATHOLOGY; INTERVENTIONAL RADIOLOGY; NONHUMAN; PROSTHESIS FAILURE; STENT; THROMBOGENESIS;

EID: 0034045251     PISSN: 10506934     EISSN: None     Source Type: Journal    
DOI: 10.1615/JLongTermEffMedImplants.v10.i12.70     Document Type: Article

References (20)

1. Schwartz, R. S., Holmes, Jr., D. R., and Topol, E. J., The restenosis paradigm revisited: An alternative proposal for cellular mechanisms, J. Am. Coll. Cardiol., 1992, 20:1284-1293.
2. Willerson, J. T., Stent restenosis: Can effective antithrombotic therapy be protective? Circulation, 1997, 96:383-385.
3. Dangas, G. and Fuster, V., Management of restenosis after coronary intervention, Am. Heart J., 1996, 132:428-436.
4. Schomig, A., Neumann, F. J., Kastrati, A., Schublen, H., Blasini, R., Hadamitzky, M., Walter, H., Zitzmann-Roth, E., Richardt, G., Alt, E., Schmitt, C., and Ulm, K., A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents, N. Engl. J. Med., 1996, 334:1084-1089.
5. Leon, M., Baim, D., Popma, J., Gordon, P. C., Cutlip, D. E., Ho, K. K., Giambartolomei, A., Diver, D. J., Lasorda, D. M., Williams, D. O., Pocock, S. J., and Kuntz, R. E., A clinical trial comparing three anti-thrombotic drug regimens after coronary-artery stenting, Stent Anticoagulation Restenosis Study Investigators (see comments), N. Engl. J. Med., 1998, 339(23): 1665-1671.
6. 111 labeled platelets: Studies on preparation and evaluation of in vitro and in vivo functions, Thromb. Res., 1976, 9:345-357.
7. Palmaz, J., Garcia, O., Kopp, D., Schatz, R. A., Tio, F. O., and Ciaravino, V., Balloon-expandable intraarterial stents: Effect of anticoagulation on thrombus formation, Circulation, 1987, 76:45.
8. Palmaz, J., Garcia, O., Kopp, D., Ciaravino, V., Schatz, R., Rees, Ca., Alvarado, R., Lancaster, J., and Borchert, R., Balloon-Expandable Intraarterial Stents: EVect of Antithrombotic Medication on Thrombus Formation, Berlin, Heidelberg: Springer, 1989.
9. Sandritter, W. and Beneke, W., Allgemeine Pathologie, Stuttgart: Schattauer, 1984.
10. Baumgartner, H. R., The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi, Microvasc. Res ., 1973, 5:167-179.
11. Baumgartner, H. R., Muggli, R., Tschopp, T. B., and Turitto, V. T., Platelet adhesion, release, and aggregation in flowing blood: Effects of surface properties and platelet function, Thromb. Haemost., 1976, 35:124-138.
12. Schultz, J. S., Lindenauer, S. M., Penner, J. A., and Barenberg, S., Determinants of thrombus formation on surfaces, Trans ASAIO, 1980, 26:279-283.
13. Hardhammar, P. A., van Beusekom, H. M., Emanuelsson, H. U., Hofma, S. H., Albertsson, P. A., Verdouw, P. D., Boersma, E., Serruys, P. W., and van der Giessen, W. J., Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries, Circulation, 1996, 93:423-430.
14. Serruys, P. W., Emanuelsson, H., van der Giessen, W., Lunn, A. C., Kiemeney, F., Macaya, C., Rutsch, W., Heyndrickx, G., Suryapranata, H., Legrand, V., Goy, J. J., Materne, P., Bonnier, H., Morice, M. C., Fajadet, J. Belardi, J., Colombo, A., Garcia, E., Ruygrok, P., de Jaegere, P., and Morel, M. A., Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the BENESTENT-II Pilot Study, Circulation, 1996, 93:412-422.
15. Elgue, G., Blomback, M., Olsson, P., and Riesenfeld, J., On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin, Thromb. Haemost., 1993, 70:289-293.
16. Barbucci, R. and Magnani, A., Conformation of human plasma proteins at polymer surfaces: The effectiveness of surface heparinization, Biomaterials, 1994, 15:955-962.
17. Schatz, R. A., Palmaz, J. C., Tio, F. O., Garcia, F., Garcia, O., and Reuter, S. R., Balloon-expandable intracoronary stents in the adult dog, Circulation, 1987, 76:450-457.
18. Foley, J. B., White, J., Teefy, P., Almond, D. G., Brown, R. I., and Penn, I. M., Late angiographic follow-up after Palmaz-Schatz stent implantation, Am. J. Cardiol., 1995, 76:76-77.
19. Kimura, T., Yokoi, H., Nakagawa, Y., Tamura, T., Kaburagi, S., Sawada, Y., Sato, Y., Yokoi, H., Hamasaki, N., Nosaka, H., and Nobuyoshi, M., Three-year follow-up after implantation of metallic coronary-artery stents [see comments], N. Engl. J. Med., 1996, 334:561-566.
20. Mattsson, E. J., Kohler, T. R., Vergel, S. M., and Clowes, A. W., Increased blood flow induces regression of intimal hyperplasia, Arterioscler. Thromb. Vasc. Biol., 1997, 17:2245-2249.